Skip to main content
. 2023 Feb 7;11:1075917. doi: 10.3389/fcell.2023.1075917

TABLE 1.

Evidence of doxorubicin-induced autophagy in the heart.

Model Targets Autophagy Treatment/Effect on DIC References
NRCM; C57BL/6J mice AMPK ↑ Increase Ghrelin/protection Wang et al. (2014)
LC3-II ↑ 3-MA/protection
Atg 5, 6, 8, 12↑ Compound C/protection
H9C2 cells, C57BL/6J mice Beclin 1 ↑ Increase Ophiopogonin-D/protection Zhang et al. (2015)
LC3II/I ↑ 3-MA/protection
NRCMs GATA4 ↓ Increase 3-MA/protection Kobayashi et al. (2010)
Bcl-2 ↓ Rapamycin/susceptibility
LC3-II ↑ autophagy flux ↑
C57BL/6 J mice; NRCM; H9C2 LC3-II ↑ Decrease Beclin1+/−/protection Li et al. (2016)
Lysosomal cathepsins ↓ Beclin1 overexpression/susceptibility
BafA1/protection
SD Rat; ARCM; AMCM; NRCM; H9C2 TFEB ↓ Decrease TFEB overexpression/protection Bartlett et al. (2016)
Cathepsin B ↓ Torin 1/protection
SD Rat; NRCM; H9C2 AMPK ↓ mTOR ↑ Decrease Astragalus polysaccharides/protection Cao et al. (2017)
LC3-II ↓
Autophagic flux ↓

NRCM, neonatal rat cardiomyocytes; ARCM, adult rat cardiomyocytes; 3-MA, 3-methyl adenine; BafA1, bafilomycin one; AMCM, adult mice cardiomyocytes; TFEB, transcription factor EB; LC3-II, microtubule-associated protein 1A/1B-light chain three; Atg, autophagy-related protein; SD, sprague dawley; ↓ decrease, ↑ increase.